AAAAAA
Results: 1-25/33
Authors:
REUTTER J
BART PA
FRANCIOLI P
SAFARY A
FREI PC
Citation: J. Reutter et al., PRODUCTION OF ANTIBODY TO HEPATITIS-A VIRUS AND HEPATITIS-B SURFACE-ANTIGEN MEASURED AFTER COMBINED HEPATITIS-A HEPATITIS-B VACCINATION IN 242 ADULT VOLUNTEERS/, Journal of viral hepatitis, 5(3), 1998, pp. 205-211
Authors:
CHIU HH
HUANG LM
LEE PI
SAFARY A
LEE CY
Citation: Hh. Chiu et al., DIPHTHERIA, TETANUS AND WHOLE-CELL PERTUSSIS-VACCINE COMBINED WITH HEPATITIS-B VACCINES - A COMPARISON OF 2 DOSES (10 MU-G AND 5 MU-G), The Pediatric infectious disease journal, 17(3), 1998, pp. 206-211
Authors:
CANEROVELASCO MC
MUTTI JE
FAY O
FAY F
SAFARY A
RUTIMAN R
FINDOR JA
SOSA A
TABORDA M
Citation: Mc. Canerovelasco et al., ANTIBODIES EVALUATION AND FOLLOW-UP (6 YEARS) OF HEALTHY-CHILDREN IMMUNIZATION WITH AN INACTIVATED HEPATITIS-A VACCINE, Hepatology, 28(4), 1998, pp. 2421-2421
Authors:
KEEFFE EB
IWARSON S
MCMAHON BJ
LINDSAY KL
KOFF RS
MANNS M
BAUMGARTEN R
WIESE M
FOURNEAU M
SAFARY A
CLEMENS R
KRAUSE DS
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Hepatology, 27(3), 1998, pp. 881-886
Authors:
THOELEN S
VANDAMME P
MATHEI C
LEROUXROELS G
DESOMBERE I
SAFARY A
VANDEPAPELIERE P
SLAOUI M
MEHEUS A
Citation: S. Thoelen et al., SAFETY AND IMMUNOGENICITY OF A HEPATITIS-B VACCINE FORMULATED WITH A NOVEL ADJUVANT SYSTEM, Vaccine, 16(7), 1998, pp. 708-714
Authors:
FAN PC
CHANG MH
LEE PI
SAFARY A
LEE CY
Citation: Pc. Fan et al., FOLLOW-UP IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN HEALTHY-CHILDREN - RESULTS AFTER 5 YEARS, Vaccine, 16(2-3), 1998, pp. 232-235
Authors:
POOVORAWAN Y
THEAMBOONLERS A
SANPAVAT S
CHUMDERMPADETSUK S
SAFARY A
VANDEPAPELIERE P
Citation: Y. Poovorawan et al., LONG-TERM ANTIBODY PERSISTENCE AFTER BOOSTER VACCINATION WITH COMBINED TETRAVALENT DIPHTHERIA, TETANUS, WHOLE-CELL BORDETELLA-PERTUSSIS ANDHEPATITIS-B VACCINE IN HEALTHY INFANTS, Annals of tropical paediatrics, 17(4), 1997, pp. 301-308
Authors:
WIEDERMANN G
KUNDI M
AMBROSCH F
SAFARY A
DHONDT E
DELEM A
Citation: G. Wiedermann et al., INACTIVATED HEPATITIS-A VACCINE - LONG-TERM ANTIBODY PERSISTENCE, Vaccine, 15(6-7), 1997, pp. 612-615
Authors:
LEROUXROELS G
DESOMBERE I
DETOLLENAERE G
PETIT MA
DESMONS P
HAUSER P
DELEM A
DEGRAVE D
SAFARY A
Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .1. SAFETY AND IMMUNOGENICITY IN YOUNG, HEALTHY-ADULTS, Vaccine, 15(16), 1997, pp. 1724-1731
Authors:
LEROUXROELS G
DESOMBERE I
COBBAUT L
PETIT MA
DESMONS P
HAUSER P
DELEM A
DEGRAVE D
SAFARY A
Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .2. IMMUNOGENICITY IN POOR RESPONDERS TO HEPATITIS-B VACCINES, Vaccine, 15(16), 1997, pp. 1732-1736
Authors:
LEE SD
CHAN CY
YU MI
WANG YJ
CHANG FY
LO KJ
SAFARY A
Citation: Sd. Lee et al., SAFETY AND IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Journal of medical virology, 52(2), 1997, pp. 215-218
Authors:
DUVAL B
BOULIANNE N
DESERRES G
DEWALS P
MASSE R
TRUDEAU G
DELAGE G
DESJARDINS L
SAFARY A
Citation: B. Duval et al., SHOULD CHILDREN WITH ISOLATED ANTI-HBS OR ANTI-HBC BE IMMUNIZED AGAINST HEPATITIS-B VIRUS, JAMA, the journal of the American Medical Association, 278(13), 1997, pp. 1064-1064
Authors:
POOVORAWAN Y
SANPAVAT S
CHUMDERMPADETSUK S
SAFARY A
Citation: Y. Poovorawan et al., LONG-TERM HEPATITIS-B VACCINE IN INFANTS BORN TO HEPATITIS-B E-ANTIGEN POSITIVE MOTHERS, Archives of Disease in Childhood, 77(1), 1997, pp. 47-51
Authors:
RAJAN E
ALBLOUSHI S
OFARRELL B
SHATTOCK A
COURTNEY MG
SAFARY A
FIELDING JF
Citation: E. Rajan et al., 2-YEAR OLD HEPATITIS-A VACCINE IS AS GOOD AS NEW, Vaccine, 14(15), 1996, pp. 1439-1441
Authors:
POOVORAWAN Y
THEAMBOONLERS A
SAFARY A
Citation: Y. Poovorawan et al., SINGLE-DOSE HEPATITIS-A VACCINATION - COMPARISON OF DIFFERENT DOSE LEVELS IN ADOLESCENTS, Vaccine, 14(12), 1996, pp. 1092-1094
Authors:
LEROUXROELS G
MOREAU E
DESOMBERE I
SAFARY A
Citation: G. Lerouxroels et al., SAFETY AND IMMUNOGENICITY OF A COMBINED HEPATITIS-A AND HEPATITIS-B VACCINE IN YOUNG HEALTHY-ADULTS, Scandinavian journal of gastroenterology, 31(10), 1996, pp. 1027-1031
Authors:
KEEFFE EB
MCMAHON BJ
KOFF RS
LINDSAY KL
MANNS M
IVARSON S
BAUMGARTEN R
WIESE M
KRAUSE DS
FOURNEAU M
SAFARY A
CLEMENS R
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Gastroenterology, 110(4), 1996, pp. 1231-1231
Authors:
LEE SD
CHAN CY
YU MI
WANG YJ
LO KJ
SAFARY A
Citation: Sd. Lee et al., SINGLE DOSE-INACTIVATED HEPATITIS-A VACCINATION SCHEDULE FOR SUSCEPTIBLE YOUNGSTERS, The American journal of gastroenterology, 91(7), 1996, pp. 1360-1362
Authors:
PAPAEVANGELOU G
KARVELIS E
ALEXIOU D
KIOSSOGLOU K
ROUMELIOTOU A
SAFARY A
COLLARD F
VANDEPAPELIERE P
Citation: G. Papaevangelou et al., EVALUATION OF A COMBINED TETRAVALENT DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS AND HEPATITIS-B CANDIDATE VACCINE ADMINISTERED TO HEALTHY INFANTS ACCORDING TO A 3-DOSE VACCINATION SCHEDULE, Vaccine, 13(2), 1995, pp. 175-178
Authors:
CLEMENS R
SAFARY A
HEPBURN A
ROCHE C
STANBURY WJ
ANDRE FE
Citation: R. Clemens et al., CLINICAL-EXPERIENCE WITH AN INACTIVATED HEPATITIS-A VACCINE, The Journal of infectious diseases, 171, 1995, pp. 44-49
Authors:
VANDAMME P
THOELEN S
MEHEUS A
SAFARY A
ANDRE FE
MATHEI C
Citation: P. Vandamme et al., SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE - RATIONALE AND CLINICAL-ASSESSMENT OF THE SAFETY AND IMMUNOGENICITY, Journal of medical virology, 44(4), 1994, pp. 435-441
Authors:
WIEDERMANN G
AMBROSCH F
ANDRE FE
DELEM A
DHONDT E
SAFARY A
Citation: G. Wiedermann et al., THERMOSTABILITY OF AN INACTIVATED HEPATITIS-A VACCINE STORED AT 37-DEGREES-C FOR ONE WEEK, Journal of medical virology, 44(4), 1994, pp. 442-442
Authors:
BRIEM H
SAFARY A
Citation: H. Briem et A. Safary, IMMUNOGENICITY AND SAFETY IN ADULTS OF HEPATITIS-A VIRUS-VACCINE ADMINISTERED AS A SINGLE-DOSE WITH A BOOSTER 6 MONTHS LATER, Journal of medical virology, 44(4), 1994, pp. 443-445
Authors:
VANDAMME P
THOELEN S
CRAMM M
DEGROOTE K
SAFARY A
MEHEUS A
Citation: P. Vandamme et al., INACTIVATED HEPATITIS-A VACCINE - REACTOGENICITY, IMMUNOGENICITY, ANDLONG-TERM ANTIBODY PERSISTENCE, Journal of medical virology, 44(4), 1994, pp. 446-451
Authors:
PRIKAZSKY V
OLEAR V
CERNOCH A
SAFARY A
ANDRE FE
Citation: V. Prikazsky et al., INTERRUPTION OF AN OUTBREAK OF HEPATITIS-A IN 2 VILLAGES BY VACCINATION, Journal of medical virology, 44(4), 1994, pp. 457-459